Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

61 Downloads (Pure)

Original language	Undefined/Unknown
Article number	1801797
Journal	European Respiratory Journal
Volume	54
Issue number	3
DOIs	https://doi.org/10.1183/13993003.01797-2018
Publication status	Published - 2019

Research programs

@article{24dc498cf5f5486fbf02466cdfe4f3fa,

title = "Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials",

author = "I Noth and \{Wijsenbeek - Lourens\}, Marlies and M Kolb and F Bonella and L Moros and D Wachtlin and TJ Corte",

year = "2019",

doi = "10.1183/13993003.01797-2018",

language = "Undefined/Unknown",

volume = "54",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials

AU - Noth, I

AU - Wijsenbeek - Lourens, Marlies

AU - Kolb, M

AU - Bonella, F

AU - Moros, L

AU - Wachtlin, D

AU - Corte, TJ

PY - 2019

Y1 - 2019

U2 - 10.1183/13993003.01797-2018

DO - 10.1183/13993003.01797-2018

M3 - Article

C2 - 31285303

SN - 0903-1936

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 3

M1 - 1801797

ER -